Purpose Of Review
Hypoxia inducible factors (HIFs) mediate the transcription of
hundreds of genes that allow cells to adapt to hypoxic environments. In this
review, we summarize the current state of knowledge about mechanisms of HIF
activation in cancer, as well as downstream cancer-promoting consequences
such as altered substrate metabolism, angiogenesis, and cell
differentiation. In addition, we examine the proposed relationship between
respiratory-related hypoxia, HIFs, and cancer.
Recent Findings
HIFs are increased in many forms of cancer, and portend a poor
prognosis and response to therapy.
Conclusion
HIFs play a critical role in various stages of carcinogenesis. HIF
and its transcription targets may be useful as biomarkers of disease and
therapeutic targets for cancer.